Pregled bibliografske jedinice broj: 812415
Liječenje vaskulitisa
Liječenje vaskulitisa // Reumatizam, 2 (2013), 47-54 (podatak o recenziji nije dostupan, pregledni rad, stručni)
CROSBI ID: 812415 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Liječenje vaskulitisa
(Treatment of vasculitis)
Autori
Novak Srđan
Izvornik
Reumatizam (0374-1338) 2
(2013);
47-54
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni
Ključne riječi
liječenje; sistemski vaskulitis
(systemic vasculitis; treatment)
Sažetak
Treatment of vasculitis depends on etiology and type of vasculitis. Gluccocorticoids are drug of choice in treatment of systemic vasculitis. While in vasculitis of large vessels treatment with gluccocorticoids is often sufficient, in ANCA associated vasculitis almost always intial combination of gluccocorticoids and immunosupresive drugs (cyclofosfamide in severe forms ; azatioprin and metotrrexate in moderate disease) is needed. Maintance therapy of ANCA associated vasculitis is methotrexate or azatioprin. From biologic therapy, in gigantocellular vasculitis treatment with tocilizumb has a great expectation, while in ANCA associated vasculitis recently rituximab was approved by regulatory agencies, and it is nontinferior to cyclofosfamide in induction of remission and prefarable in relapsing disease.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE